Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Pirfenidone (CAS 53179-13-8)

5.0(1)
Write a reviewAsk a question

See product citations (6)

Alternate Names:
5-Methyl-1-phenyl-2-(1H)-pyridone
Application:
Pirfenidone is an antifibrotic and antioxidant small molecule
CAS Number:
53179-13-8
Purity:
≥99%
Molecular Weight:
185.23
Molecular Formula:
C12H11NO
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Pirfenidone is a small molecule antifibrotic agent. In pulmonary fibrosis studies, Pirfenidone is shown to block collagen production and mitigate the presentation of bleomycin- and cyclophosphamide-induced fibrosis. This intervention appears in part on the transcriptional level, with Pirfenidone exposure correlating to a significant decrease in levels of procollagen I and III gene-assoicated messenger RNA. The antioxidant radical-scavenging activity additionally demonstrated by Pirfenidone suggests a role in protecting against lipid peroxidation, and may attribute to the antifibrotic property of the compound.


Pirfenidone (CAS 53179-13-8) References

  1. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.  |  Iyer, SN., et al. 1999. J Pharmacol Exp Ther. 289: 211-8. PMID: 10087006
  2. Effects of pirfenidone on the generation of reactive oxygen species in vitro.  |  Giri, SN., et al. 1999. J Environ Pathol Toxicol Oncol. 18: 169-77. PMID: 15281229
  3. Protection of pirfenidone against an early phase of oleic acid-induced acute lung injury in rats.  |  Mei, S., et al. 2005. J Pharmacol Exp Ther. 313: 379-88. PMID: 15608079
  4. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.  |  Antoniu, SA. 2006. Expert Opin Investig Drugs. 15: 823-8. PMID: 16787145
  5. Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.  |  Azuma, A. 2010. Expert Rev Respir Med. 4: 301-10. PMID: 20524912
  6. Pirfenidone in idiopathic pulmonary fibrosis.  |  Maher, TM. 2010. Drugs Today (Barc). 46: 473-82. PMID: 20683502
  7. Antifibrotic activities of pirfenidone in animal models.  |  Schaefer, CJ., et al. 2011. Eur Respir Rev. 20: 85-97. PMID: 21632796
  8. Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis.  |  Hilberg, O., et al. 2012. Clin Respir J. 6: 131-43. PMID: 22697264
  9. The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis.  |  Cottin, V. 2013. Respir Res. 14 Suppl 1: S5. PMID: 23734908
  10. Pirfenidone. First, do no harm.  |  . 2013. Prescrire Int. 22: 117-9. PMID: 23819168
  11. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.  |  Xaubet, A., et al. 2014. Expert Opin Pharmacother. 15: 275-81. PMID: 24308635
  12. Functional and structural impact of pirfenidone on the alterations of cardiac disease and diabetes mellitus.  |  Avila, G., et al. 2014. Cell Calcium. 56: 428-35. PMID: 25108569
  13. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.  |  Poletti, V., et al. 2014. Expert Rev Respir Med. 8: 539-45. PMID: 25113033
  14. Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice.  |  Kehrer, JP. and Margolin, SB. 1997. Toxicol Lett. 90: 125-32. PMID: 9067480
  15. Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production.  |  Lee, BS., et al. 1998. J Clin Endocrinol Metab. 83: 219-23. PMID: 9435445

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Pirfenidone, 10 mg

sc-203663
10 mg
$102.00

Pirfenidone, 50 mg

sc-203663A
50 mg
$416.00

Is it available for supply in India?

Asked by: Anonymous
Thank you for your question. For accurate availability, pricing and shipping information regarding this chemical, please contact your local distributor for assistance.
Answered by: Technical Service 4
Date published: 2020-11-12

Pregunta relacionada con pirfenidone: sc-203663. ¿Cuales son las condiciones óptimas para guardar la solución stock de pirfenidone?. Gracias. Alfonso.

Asked by: Alfonso
Muchas gracias por su pregunta. Se recomienda utilizar las diluciones el mismo día que se hacen. Si necesita almacenar las soluciones, puede aliquotarlas en tamaños de trabajo y congelarlas. Debe evitar ciclos de congelado - descongealdo.
Answered by: Technical Support Europe
Date published: 2017-12-06
  • y_2026, m_4, d_29, h_11CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_2
  • loc_en_US, sid_203663, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 136ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Manzanares D; et alManzanares D; et al. (PubMed ID: 26338706) determined that Pirfenidone, a TGF- signaling inhibitor, was able to reverse TGF- 1-induced ASL volume hyperabsorption, in fully differentiated cystic fibrosis bronchial epithelial cells. -SCBT Publication Review
Date published: 2015-02-01
  • y_2026, m_4, d_29, h_11
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203663, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 15ms
  • REVIEWS, PRODUCT
Pirfenidone is rated 5.0 out of 5 by 1.
  • y_2026, m_4, d_29, h_11
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203663, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 155ms
  • REVIEWS, PRODUCT